Antibiotic API Industry Research Report 2024

Antibiotic API Industry Research Report 2024


Summary

According to APO Research, the global Antibiotic API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Antibiotic API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Antibiotic API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Antibiotic API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Antibiotic API include UNITED LABORATORIES, North China Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, Centrient Pharmaceuticals, Aurobindo Pharma, Shyndec Pharmaceutical, Nectar Lifesciences, Harbin Pharmaceutical Group and ACS Dobfar, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibiotic API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic API.

The report will help the Antibiotic API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Antibiotic API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibiotic API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL
Antibiotic API segment by Type

Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others
Antibiotic API segment by Application

Oral Medicine
Injection Medicine
Antibiotic API Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotic API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibiotic API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotic API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antibiotic API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antibiotic API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antibiotic API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Antibiotic API Market Size (2019-2030) & (US$ Million)
2.2.2 Global Antibiotic API Sales (2019-2030)
2.2.3 Global Antibiotic API Market Average Price (2019-2030)
2.3 Antibiotic API by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Penicillins
2.3.3 Cephalosporins
2.3.4 Aminoglycosides
2.3.5 Tetracyclines
2.3.6 Quinolones
2.3.7 Macrolides
2.3.8 Lincomycins
2.3.9 Others
2.4 Antibiotic API by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Oral Medicine
2.4.3 Injection Medicine
3 Market Competitive Landscape by Manufacturers
3.1 Global Antibiotic API Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Antibiotic API Sales (Tons) of Manufacturers (2019-2024)
3.3 Global Antibiotic API Revenue of Manufacturers (2019-2024)
3.4 Global Antibiotic API Average Price by Manufacturers (2019-2024)
3.5 Global Antibiotic API Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Antibiotic API, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Antibiotic API, Product Type & Application
3.8 Global Manufacturers of Antibiotic API, Date of Enter into This Industry
3.9 Global Antibiotic API Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 UNITED LABORATORIES
4.1.1 UNITED LABORATORIES Company Information
4.1.2 UNITED LABORATORIES Business Overview
4.1.3 UNITED LABORATORIES Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.1.4 UNITED LABORATORIES Antibiotic API Product Portfolio
4.1.5 UNITED LABORATORIES Recent Developments
4.2 North China Pharmaceutical
4.2.1 North China Pharmaceutical Company Information
4.2.2 North China Pharmaceutical Business Overview
4.2.3 North China Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.2.4 North China Pharmaceutical Antibiotic API Product Portfolio
4.2.5 North China Pharmaceutical Recent Developments
4.3 RUIYING PIONEER PHARMACEUTICAL
4.3.1 RUIYING PIONEER PHARMACEUTICAL Company Information
4.3.2 RUIYING PIONEER PHARMACEUTICAL Business Overview
4.3.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.3.4 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Portfolio
4.3.5 RUIYING PIONEER PHARMACEUTICAL Recent Developments
4.4 Centrient Pharmaceuticals
4.4.1 Centrient Pharmaceuticals Company Information
4.4.2 Centrient Pharmaceuticals Business Overview
4.4.3 Centrient Pharmaceuticals Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Centrient Pharmaceuticals Antibiotic API Product Portfolio
4.4.5 Centrient Pharmaceuticals Recent Developments
4.5 Aurobindo Pharma
4.5.1 Aurobindo Pharma Company Information
4.5.2 Aurobindo Pharma Business Overview
4.5.3 Aurobindo Pharma Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Aurobindo Pharma Antibiotic API Product Portfolio
4.5.5 Aurobindo Pharma Recent Developments
4.6 Shyndec Pharmaceutical
4.6.1 Shyndec Pharmaceutical Company Information
4.6.2 Shyndec Pharmaceutical Business Overview
4.6.3 Shyndec Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Shyndec Pharmaceutical Antibiotic API Product Portfolio
4.6.5 Shyndec Pharmaceutical Recent Developments
4.7 Nectar Lifesciences
4.7.1 Nectar Lifesciences Company Information
4.7.2 Nectar Lifesciences Business Overview
4.7.3 Nectar Lifesciences Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Nectar Lifesciences Antibiotic API Product Portfolio
4.7.5 Nectar Lifesciences Recent Developments
4.8 Harbin Pharmaceutical Group
4.8.1 Harbin Pharmaceutical Group Company Information
4.8.2 Harbin Pharmaceutical Group Business Overview
4.8.3 Harbin Pharmaceutical Group Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Harbin Pharmaceutical Group Antibiotic API Product Portfolio
4.8.5 Harbin Pharmaceutical Group Recent Developments
4.9 ACS Dobfar
4.9.1 ACS Dobfar Company Information
4.9.2 ACS Dobfar Business Overview
4.9.3 ACS Dobfar Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.9.4 ACS Dobfar Antibiotic API Product Portfolio
4.9.5 ACS Dobfar Recent Developments
4.10 Novartis
4.10.1 Novartis Company Information
4.10.2 Novartis Business Overview
4.10.3 Novartis Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Novartis Antibiotic API Product Portfolio
4.10.5 Novartis Recent Developments
4.11 CSPC
4.11.1 CSPC Company Information
4.11.2 CSPC Business Overview
4.11.3 CSPC Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.11.4 CSPC Antibiotic API Product Portfolio
4.11.5 CSPC Recent Developments
4.12 QILU ANTIBIOTICS PHARMACEUTICAL
4.12.1 QILU ANTIBIOTICS PHARMACEUTICAL Company Information
4.12.2 QILU ANTIBIOTICS PHARMACEUTICAL Business Overview
4.12.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.12.4 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Portfolio
4.12.5 QILU ANTIBIOTICS PHARMACEUTICAL Recent Developments
4.13 REYOUNG
4.13.1 REYOUNG Company Information
4.13.2 REYOUNG Business Overview
4.13.3 REYOUNG Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.13.4 REYOUNG Antibiotic API Product Portfolio
4.13.5 REYOUNG Recent Developments
4.14 Orchid Pharma
4.14.1 Orchid Pharma Company Information
4.14.2 Orchid Pharma Business Overview
4.14.3 Orchid Pharma Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Orchid Pharma Antibiotic API Product Portfolio
4.14.5 Orchid Pharma Recent Developments
4.15 FUAN PHARMACEUTICAL
4.15.1 FUAN PHARMACEUTICAL Company Information
4.15.2 FUAN PHARMACEUTICAL Business Overview
4.15.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.15.4 FUAN PHARMACEUTICAL Antibiotic API Product Portfolio
4.15.5 FUAN PHARMACEUTICAL Recent Developments
4.16 Dongying Pharmaceutical
4.16.1 Dongying Pharmaceutical Company Information
4.16.2 Dongying Pharmaceutical Business Overview
4.16.3 Dongying Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Dongying Pharmaceutical Antibiotic API Product Portfolio
4.16.5 Dongying Pharmaceutical Recent Developments
4.17 FUKANG PHARMACEUTICAL
4.17.1 FUKANG PHARMACEUTICAL Company Information
4.17.2 FUKANG PHARMACEUTICAL Business Overview
4.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.17.4 FUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
4.17.5 FUKANG PHARMACEUTICAL Recent Developments
4.18 Medya Pharmaceutical
4.18.1 Medya Pharmaceutical Company Information
4.18.2 Medya Pharmaceutical Business Overview
4.18.3 Medya Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Medya Pharmaceutical Antibiotic API Product Portfolio
4.18.5 Medya Pharmaceutical Recent Developments
4.19 LUKANG PHARMACEUTICAL
4.19.1 LUKANG PHARMACEUTICAL Company Information
4.19.2 LUKANG PHARMACEUTICAL Business Overview
4.19.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.19.4 LUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
4.19.5 LUKANG PHARMACEUTICAL Recent Developments
4.20 Dawnrays Pharmaceutical
4.20.1 Dawnrays Pharmaceutical Company Information
4.20.2 Dawnrays Pharmaceutical Business Overview
4.20.3 Dawnrays Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Dawnrays Pharmaceutical Antibiotic API Product Portfolio
4.20.5 Dawnrays Pharmaceutical Recent Developments
4.21 SALUBRIS
4.21.1 SALUBRIS Company Information
4.21.2 SALUBRIS Business Overview
4.21.3 SALUBRIS Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.21.4 SALUBRIS Antibiotic API Product Portfolio
4.21.5 SALUBRIS Recent Developments
4.22 KELUN
4.22.1 KELUN Company Information
4.22.2 KELUN Business Overview
4.22.3 KELUN Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.22.4 KELUN Antibiotic API Product Portfolio
4.22.5 KELUN Recent Developments
4.23 HUAFANG PHARMACEUTICAL
4.23.1 HUAFANG PHARMACEUTICAL Company Information
4.23.2 HUAFANG PHARMACEUTICAL Business Overview
4.23.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2019-2024)
4.23.4 HUAFANG PHARMACEUTICAL Antibiotic API Product Portfolio
4.23.5 HUAFANG PHARMACEUTICAL Recent Developments
5 Global Antibiotic API Market Scenario by Region
5.1 Global Antibiotic API Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Antibiotic API Sales by Region: 2019-2030
5.2.1 Global Antibiotic API Sales by Region: 2019-2024
5.2.2 Global Antibiotic API Sales by Region: 2025-2030
5.3 Global Antibiotic API Revenue by Region: 2019-2030
5.3.1 Global Antibiotic API Revenue by Region: 2019-2024
5.3.2 Global Antibiotic API Revenue by Region: 2025-2030
5.4 North America Antibiotic API Market Facts & Figures by Country
5.4.1 North America Antibiotic API Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Antibiotic API Sales by Country (2019-2030)
5.4.3 North America Antibiotic API Revenue by Country (2019-2030)
5.4.4 United States
5.4.5 Canada
5.5 Europe Antibiotic API Market Facts & Figures by Country
5.5.1 Europe Antibiotic API Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Antibiotic API Sales by Country (2019-2030)
5.5.3 Europe Antibiotic API Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Antibiotic API Market Facts & Figures by Country
5.6.1 Asia Pacific Antibiotic API Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Antibiotic API Sales by Country (2019-2030)
5.6.3 Asia Pacific Antibiotic API Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 Latin America Antibiotic API Market Facts & Figures by Country
5.7.1 Latin America Antibiotic API Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Antibiotic API Sales by Country (2019-2030)
5.7.3 Latin America Antibiotic API Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Antibiotic API Market Facts & Figures by Country
5.8.1 Middle East and Africa Antibiotic API Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Antibiotic API Sales by Country (2019-2030)
5.8.3 Middle East and Africa Antibiotic API Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Antibiotic API Sales by Type (2019-2030)
6.1.1 Global Antibiotic API Sales by Type (2019-2030) & (Tons)
6.1.2 Global Antibiotic API Sales Market Share by Type (2019-2030)
6.2 Global Antibiotic API Revenue by Type (2019-2030)
6.2.1 Global Antibiotic API Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Antibiotic API Revenue Market Share by Type (2019-2030)
6.3 Global Antibiotic API Price by Type (2019-2030)
7 Segment by Application
7.1 Global Antibiotic API Sales by Application (2019-2030)
7.1.1 Global Antibiotic API Sales by Application (2019-2030) & (Tons)
7.1.2 Global Antibiotic API Sales Market Share by Application (2019-2030)
7.2 Global Antibiotic API Revenue by Application (2019-2030)
7.2.1 Global Antibiotic API Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Antibiotic API Revenue Market Share by Application (2019-2030)
7.3 Global Antibiotic API Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Antibiotic API Value Chain Analysis
8.1.1 Antibiotic API Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Antibiotic API Production Mode & Process
8.2 Antibiotic API Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Antibiotic API Distributors
8.2.3 Antibiotic API Customers
9 Global Antibiotic API Analyzing Market Dynamics
9.1 Antibiotic API Industry Trends
9.2 Antibiotic API Industry Drivers
9.3 Antibiotic API Industry Opportunities and Challenges
9.4 Antibiotic API Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings